Funded Tech Companies

Nurix Therapeutics

Headquartered in San Francisco, Nurix Therapeutics raised its funding from Boxer Capital, The Column Group and Third Rock Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Nurix Therapeutics (Nasdaq: NRIX) is focused on the discovery and development of small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/23/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Arthur Sands

        

Vice President

Jean Chang

        

Vice President

Cristiana Guiducci

        

VP - Bus. Development

Pierre Beaurang

        

VP - Finance

Hans Houte

        

VP - General Counsel

Christine Ring

        

VP - R & D

Gwenn Hansen

        

Company Investors

• Boxer Capital
• The Column Group
• Third Rock Ventures
• Wellington Management Company
• Foresite Capital (Michael Rome)
• EcoR1 Capital Management
• Bain Capital Life Sciences
• Redmile Group
• The Column Group (Timothy Kutzkey)
• Third Rock Ventures (Mark Goldsmith)

Browse more funded tech companies:

Nuritas | Nuro

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary